Skip to main content
Log in

Activity of blood coagulation Factor XIII as a prognostic indicator in patients with Henoch-Schönlein purpura

Efficacy of Factor XIII substitution

  • Original Investigations
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Determination of coagulation Factor XIII (F XIII)-related parameters in 21 patients with Henoch-Schönlein purpura documented a significant decrease of F XIII activity as well as of the F XIII-related antigenic determinants. Subgroup analysis with regard to the clinical symptoms showed an even further decrease of these parameters in patients with gastrointestinal complications. Stimulated by these findings a substitution therapy with a F XIII concentrate was initiated in those patients whose F XIII activity in plasma remained low and who developed severe abdominal pain accompanied by persisting gastrointestinal bleeding. This therapeutic approach not only corrected the laboratory data, but more important led to a cessation of pain and bleeding. A rapid decrease of F XIII levels after transfusion below 40 U/ml was indicative of relapse of abdominal symptoms, while increasing values were associated with the recovery of the patients. In conclusion: F XIII activity determinations appear to have a predictive value in patients with Henoch-Schönlein purpura, and the administration of F XIII concentrates may contribute to the improvement of gastrointestinal complications.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

F XIII:

Factor XIII

SHP:

Henoch-Schönlein purpura

XIII-act:

Factor XIII activity

MCA:

monochloroacetic acid

XIII-A:

Factor XIII subunit A antigen

XIII-S:

Factor XIII subunit S antigen

F VIII R:AG:

Factor VIII related antigen

FDP:

Fibrin degradation products

F VIII:C:

Factor VIII coagulant activity

References

  1. Bohn H (1972) Comparative studies of the fibrin-stabilizing factors from human plasma, platelets and placenta. Ann N Y Acad Sci 202:256–272

    Google Scholar 

  2. Egbring R, Schmidt W, Fuchs G, Havemann K (1977) Demonstration of granulocytic protease in plasma of patients with acute leukemia and septicemia with coagulation defects. Blood 49:219–231

    Google Scholar 

  3. Fukui H, Yoshiya H, Katagiri S, Yoshioka A, Mikami S, Okuda T, Niida T, Daida K, Yoshida K (1974) Congenital factor XIII (fibrin stabilizing factor) deficiency; report of three cases. Jpn J Clin Hematol 15:191–200

    Google Scholar 

  4. Hardisty RM, MacPherson JC, Ingram GIC (1962) A one-stage factor VIII (antihemophilic globulin) assay and its use on venous and capillary plasma. Thromb Diath Haemorrh 7:215–229

    Google Scholar 

  5. Henriksson P, Hedner U, Nilsson IM, Nilsson PG (1975) Generalized proteolysis in a young woman with Weber-Christian disease (modular non-suppurative panniculitis). Scand J Haematol 14: 355–360

    Google Scholar 

  6. Henriksson P, hedner U, Nilsson IM (1977) Factor XIII (fibrin stabilizing factor) in Henoch-Schönlein's purpura. Acta Pediatr Scand 66:273–277

    Google Scholar 

  7. Henriksson P, Nilsson IM, Oklsson K, Stenberg P (1980) Granulocyte elastase activation and degradation of factor XIII. Thromb Res 18:343–351

    Google Scholar 

  8. Kataoka S, Haneda M, Morita K, Koyama K (1975) Studies on determination of plasma fibrinogen using TG-meter. Jpn J Clin Path 23:466–470

    Google Scholar 

  9. Laki K, Lorand L (1948) On the solubility of fibrin clots. Science 108:280

    Google Scholar 

  10. Laurell CB (1966) Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem 15: 45–52

    Google Scholar 

  11. Loewy AG, Dunatham K, Kriel R, Wolfinger HL Jr (1960) Fibrinase 1. Purification of substrate and enzyme. J Biol Chem 236: 2625–2633

    Google Scholar 

  12. Nilsson IM, Bergentz SE, Wiklander O, Hedner U (1975) Erosive hemorrhagic gastroduodenitis with fibrinolysis and low factor XIII. Ann Surg 182:677–682

    Google Scholar 

  13. Schmidt W, Egbring R, Havemann K (1975) Effect of elastase-like and chymotrypsin-like natural proteases from human granulocytes on isolated clotting factors. Thromb Res 6:315–326

    Google Scholar 

  14. Schwartz ML, Pizzo SV, Hill RL, McKee PA (1973) Human factor XIII from plasma and platelets. J Biol Chem 248:1395–1407

    Google Scholar 

  15. Tani K (1979) Studies on factor XIII in children with various renal diseases. I. Plasma factor XIII activity, factor XIII subunit-A antigen and factor XIII subunit S antigen. J Nara Med Ass 30:262–270

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kamitsuji, H., Tani, K., Yasui, M. et al. Activity of blood coagulation Factor XIII as a prognostic indicator in patients with Henoch-Schönlein purpura. Eur J Pediatr 146, 519–523 (1987). https://doi.org/10.1007/BF00441608

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00441608

Key words

Navigation